Group One Trading’s Opus Genetics IRD Stock Holding History

Group One Trading’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$6.02K	–	8120
2023 Q4	$6.02K	Sell	2,000 -11,000	-85%	-$32.5K	﹤0.01%	6440
2023 Q3	$43.5K	Buy	+13,000	New	+$52.2K	﹤0.01%	5230
2022 Q3	–	Sell	-300	Closed	-$1K	–	8384
2022 Q2	$1K	Hold	300	–	–	﹤0.01%	7650
2022 Q1	$1K	Sell	300 -4,700	-94%	-$16.1K	﹤0.01%	7898
2021 Q4	$19K	Sell	5,000 -20,400	-80%	-$81.8K	﹤0.01%	7016
2021 Q3	$131K	Buy	25,400 +23,200	+1,055%	+$107K	﹤0.01%	5630
2021 Q2	$12K	Buy	+2,200	New	+$10.9K	﹤0.01%	7464

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Group One Trading's IRD Position: Q1 2026 in Review

Group One Trading opened a new position in Opus Genetics (IRD) in Q1 2026: 10,594 shares worth $48.2K. The stake represents ﹤0.01% of the portfolio and ranks #5285 among its holdings. This is a return to the name: Group One Trading previously reported a position in IRD as recently as Q2 2024.

Group One Trading first reported a position in IRD in Q3 2017 and has held it in 12 quarters since. The position peaked at $163K in Q3 2021. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Group One Trading held 10,594 shares of Opus Genetics worth $48.2K as of Q1 2026.
Opus Genetics was a new Group One Trading position in Q1 2026.
Opus Genetics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5285 holding.
Group One Trading first reported a position in Opus Genetics in Q3 2017 and has held it in 12 quarters since.
Group One Trading's Opus Genetics position peaked at $163K in Q3 2021.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.